Navigation Links
Uganda Bans Plastic Bags, Still a Tough Battle Lies Ahead

As is the case with most other developing countries, plastic bags have become a terrible environmental threat in Uganda.

As the situation seems to be spiraling out of control, the government has announced a ban on the all pervasive plastic bags.

In Uganda they are called buveera , and they are everywhere.

Only a tiny fraction of them end up at an organized dump like the one at Chitezi in Ugandan capital Kampala. Instead, once discarded, they are blown in the wind, washed into drains and water courses and eventually ground into the earth.

The country is blessed with some of the richest soil in Africa, but around the towns and villages it is laced with plastic.

New strata are forming - a layer cake of polythene and poisoned soil, through which Uganda's rains can never percolate.

In the slums and shanties buveera are breeding grounds for disease.

With no mains water and no sewerage system, the bags are used as toilets. Flying latrines they are called, because when you have filled them, you throw them as far away as you can.

And when the rains come and wash them out there is a good chance that some little boy or girl sent on an errand will see a bag in the street and use it again, to carry firewood or maybe food.

After a fair amount of stalling, the government announced that from 1 July the manufacture, import and use of plastic bags thinner than 30 microns was being banned. All other polythene would be subject to a whopping 120% tax.

The country's environment minister, Jesca Eriyo, conceded that that she was embarrassed by her capital city's lamentable standards of waste management; by the Chitezi dump; by its sea of polythene, and its flying latrines.

Now, at last, they could all be headed for the exit door. And not just in Uganda. Neighbouring Kenya is introducing similar legislation. Tanzania wants to go even further and ban plastic drinks co
'"/>




Page: 1 2

Related medicine news :

1. Ebola Virus - Outbreak Claims More Lives In Uganda.
2. Uganda Reports Failure To Contain Sleeping Sickness
3. Ban on Global fund lifted in Uganda
4. HIV/AIDS Throws Family Relationships Out Of Gear In Uganda
5. Uganda Tackles The Meningitis Outbreak
6. Uganda Facing Huge Problem Due to Combination of HIV And TB
7. Uganda Faces Crisis in the Field Of HIV/AIDS Due To Budget Cuts
8. Uganda Shows Increased HIV Discordant Couples
9. Depleting stock of antiretroviral drugs in Uganda raises concern
10. More Ugandan Men Seek Circumcision In 2006
11. HIV Home-based Care Produces Positive Outcomes in Uganda
Post Your Comments:
Breaking Medicine Technology:Nearly 100 HIV/AIDS Drugs and Vaccines in Development Pipeline 2New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 2New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 3New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8PROSTVAC 28TM 29 Data Presented at the ASCO Meeting Demonstrates the Potential for Significant Increases in Life Expectancy in Late Stage Prostate Can 12379 1PROSTVAC 28TM 29 Data Presented at the ASCO Meeting Demonstrates the Potential for Significant Increases in Life Expectancy in Late Stage Prostate Can 12379 2PROSTVAC 28TM 29 Data Presented at the ASCO Meeting Demonstrates the Potential for Significant Increases in Life Expectancy in Late Stage Prostate Can 12379 3Valeant Pharmaceuticals Reports Encouraging Final Results With Taribavirin Phase IIb Study 12376 1Valeant Pharmaceuticals Reports Encouraging Final Results With Taribavirin Phase IIb Study 12376 2Valeant Pharmaceuticals Reports Encouraging Final Results With Taribavirin Phase IIb Study 12376 3Valeant Pharmaceuticals Reports Encouraging Final Results With Taribavirin Phase IIb Study 12376 4Back to normal 3A Surgery improves outcomes for spine patients 47438 1Back to normal 3A Surgery improves outcomes for spine patients 47438 2